| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | +38.4% |
| Cost of Revenue | $3.5M | -5.8% |
| Gross Profit | $4.3M | +124.7% |
| R&D Expense | $2.4M | -11.8% |
| SG&A Expense | $3.2M | -10.3% |
| Operating Income | -$3.8M | +49.0% |
| Interest Expense | -$91K | -130.8% |
| Net Income | -$4.4M | +30.4% |
| EPS (Basic) | -$0.85 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | +217.3% |
| Short-term Investments | $197K | +0.0% |
| Accounts Receivable | $1.6M | +143.4% |
| Inventory | $2.4M | -3.6% |
| Current Assets | $6.9M | +16.8% |
| Total Assets | $8.2M | -26.7% |
| Current Liabilities | $4.6M | -33.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | +0.4% |
| Capital Expenditures | $1K | -88.9% |
| Investing Cash Flow | $197K | -94.8% |
| Financing Cash Flow | $3.1M | -17.8% |
| Free Cash Flow | -$6.5M | +0.5% |
| +67.4% |
| EPS (Diluted) | -$0.85 | +67.4% |
| Long-term Debt |
| $150K |
| +1.4% |
| Total Liabilities | $5.2M | -51.6% |
| Stockholders' Equity | $2.8M | +1103.9% |